top of page

Remote Neuromodulation

Deployed transcranial electrical stimulation, without compromise.

System Components:


Safe transcranial Electrical Stimulation requires advanced systems designed for consistency, control and supervision.

Soterix Medical REMOTE Neuromodulation (ARTG Entry: 284637) is the only system with devices, accessories, and software designed for deployed use.


REMOTE Neuromodulation is the only system designed from the ground up to allow translation of clinical tES, including tDCS protocols, to diverse deployed environments, while maintaining medical standards.


Soterix Medical REMOTE is supported by over a dozen clinical trials including the demonstration of tolerability, reproducibility, and compliance[1-13].


mini-CT device  

Fail-safe and intelligent hand-held stimulators designed specifically for deployed use. Deliver only the right dose at the right time, with onboard compliance recording and ElectraRx compatibility. 

SNAP Headgear accessories

The only head-gear that is simple to self-apply and guarantees accurate electrode placement. The only pre-saturated snap electrodes for tES in deployed environment.

ElectraRx software  

ElectraRx integrates complete screening and assessments, tDCS dose management, and online digital therapeutics all in one place that can be accessed from anywhere.

Depression tDCS-LTE™ System

Deployed transcranial electrical stimulation, without compromise.

34% symptom reduction in Major Depression

tDCS-LTE offers a non-invasive, sedation-free, and seizure-risk-free approach for the treatment of major depression, with virtually no side effects.

1 month of sustained antidepressant response post-stimulation

tDCS-LTE delivers optimized and personalized stimulation. The most effective and tolerated stimulation requires intelligent tDCS-LTE technology.

PainX™ tDCS System

Clinical-grade intelligent tDCS for pain therapy

50%  or more reduction


in Fibromyalgia in 50% of subjects

The clinical trial from Harvard Medical Schools shows dramatic Fibromyalgia pain relief starting in just two weeks, with no significant side-effects.

37% or more reduction in 

Migraine with less and shorter attacks 

Starting in just four weeks, effectiveness greater than pharmacological drugs with minimal side effects based on clinical trial results.

1 x 1 Clinical Trail System

The most advanced and customizable system for true double-blind control trials

Four features for double-blind clinical trials:

True operator blinding





[1] Delivering Transcranial Direct Current Stimulation Away From Clinic: Remotely Supervised tDCS. Mil Med. 2020 

[2] Telerehabilitation benefits patients with multiple sclerosis in an urban setting.  J Telemed Telecare. 2019

[3] Long term at-home treatment with transcranial direct current stimulation(tDCS) improves symptoms of cerebellar ataxia: a case report. J Neuroeng Rehabil. 2019

[4] Introducing the thematic series on transcranial direct current stimulation (tDCS) for motor rehabilitation: on the way to optimal clinical use. J Neuroeng Rehabil. 2019

[5] Generalizing remotely supervised tDCS: feasibility and benefit in Parkinson's disease. J Neuroeng Rehabil 2018

[6] Remotely-supervised tDCS paired with cognitive training in Parkinson's disease: An open-label study. J Clin Neurosci 2018 Nov

[7] Remotely supervised tDCS for the treatment of fatigue in multiple sclerosis: Results from a randomized, sham-controlled trial. Scler. 2018

[8] Transcranial Direct Current Stimulation Is Feasible for Remotely Supervised Home Delivery in Multiple Sclerosis. Neuromodulation 20

[9] Remotely Supervised tDCS Increases the Benefit of At-Home Cognitive Training in Multiple Sclerosis. Neuromodulation 2018

[10] At-Home tDCS With Telehealth Support for Symptom Control in Chronically-Ill Patients With Multiple Symptoms Front Behav Neurosci 201

[11] Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability J Vis Exp. 2017

[12] A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation (tDCS) in Multiple Sclerosis (MS). J Vis Exp. 2015

[13] Remotely-supervised tDCS for clinical trials: guidelines for technology and protocols. Front Syst Neurosci. 2015

bottom of page